
NAD IV Therapy: A Natural Support for Your Energy and Vitality
In recent years, approaches that aim to support healthy aging and cellular well-being have become increasingly popular. Among these, NAD IV Therapy has drawn attention as a promising modality within the field of wellness. With its potential to promote energy metabolism, support cognitive performance, and contribute to overall vitality, NAD IV Therapy is a valued option for individuals seeking advanced wellness support.
What Is NAD IV Therapy?
NAD (Nicotinamide Adenine Dinucleotide) is a naturally occurring coenzyme found in all living cells. It plays a key role in various biological processes, including energy production, DNA repair, and cell regeneration. However, as part of the natural aging process, NAD levels in the body tend to decline over time. This decline may be associated with reduced cellular efficiency and vitality.
NAD IV Therapy is an intravenous method of delivering NAD directly into the bloodstream. This allows for rapid absorption and may help support cellular health, energy metabolism, and overall physiological resilience.
NAD IV Therapy at Only Health
At Only Health, we offer NAD IV Therapy within a medically supervised, safe, and comfortable setting. Our team of healthcare professionals evaluates your individual needs and develops a personalized support plan accordingly.
Our approach is grounded in the principles of integrative wellness, utilizing the most advanced technology and protocols available to help support your vitality, focus, and quality of life.
Potential Benefits of NAD IV Therapy
- Energy and Vitality:
May help support natural energy production at the cellular level, contributing to a more sustained sense of vitality throughout the day. - Cognitive Support:
NAD is involved in cellular processes that may assist with focus, clarity, and memory functions. - Healthy Aging Support:
By assisting in cellular regeneration mechanisms, NAD IV Therapy may support the body’s natural aging process in a more balanced way. - Immune & Inflammatory Balance:
May contribute to cellular repair processes and support the body’s ability to manage inflammation.
References:
- Braidy, N., Berg, J., Clement, J., Khorshidi, F., Poljak, A., Jayasena, T., Grant, R., & Sachdev, P. (2019). Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. Antioxidants & Redox Signaling, 30(2), 251–294.
https://doi.org/10.1089/ars.2017.7269
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277084/ - Covarrubias, A. J., Perrone, R., Grozio, A., et al. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22, 119–141.
https://doi.org/10.1038/s41580-020-00313-x
https://www.nature.com/articles/s41580-020-00313-x - The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition (NAD). (ClinicalTrials.gov ID: NCT02942888). Sponsor: The University of Texas Health Science Center at San Antonio. Information provided by The University of Texas Health Science Center at San Antonio (Responsible Party). Last Update Posted 2021-09-02.
https://clinicaltrials.gov/study/NCT02942888?tab=history - Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism, 27(3), 529–547.
https://doi.org/10.1016/j.cmet.2018.02.011
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342515/ - Rappou, E., Jukarainen, S., Rinnankoski-Tuikka, R., Kaye, S., Heinonen, S., Hakkarainen, A., Lundbom, J., Lundbom, N., Saunavaara, V., Rissanen, A., Virtanen, K. A., Pirinen, E., & Pietiläinen, K. H. (2016). Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue. The Journal of Clinical Endocrinology & Metabolism, 101(3), 1263-1273.
https://doi.org/10.1210/jc.2015-3054
https://pubmed.ncbi.nlm.nih.gov/26760174/ - Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208-1213.
https://doi.org/10.1126/science.aac485
https://www.science.org/doi/10.1126/science.aac4854 - Johnson, S., & Imai, S. (2018). NAD+ biosynthesis, aging, and disease. Version 1. F1000Research, 7, 132.
https://doi.org/10.12688/f1000research.12120.1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795269/ - Braidy, N., & Liu, Y. (2020). NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Experimental Gerontology, 132, 110831.
https://doi.org/10.1016/j.exger.2020.110831
https://pubmed.ncbi.nlm.nih.gov/31917996/